BAJAJ BROKING

Notification
No new Notification messages
Vishal Mega Mart IPO is Open!
Apply for the Vishal Mega Mart IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
biofil chem & pharma ltd stock

BIOFIL CHEM & PHARMA LTD Share Price

63.33 -1.34 (-2.07%)
Dec 12 2024 03:30 PM Pharmaceuticals NSE: BIOFILCHEM

BIOFIL CHEM & PHARMA LTD Share Price Update

As of the latest trading session, BIOFIL CHEM & PHARMA LTD share price is currently at 63.33, which is down by -1.34 from its previous closing. Today, the stock has fluctuated between 62.30 and 66.24. Over the past year, BIOFIL CHEM & PHARMA LTD has achieved a return of 24.98 %. In the last month alone, the return has been 0.27 %. Read More...

BIOFIL CHEM & PHARMA LTD Performance

Day Range

Low62.30 High66.24
63.79

52 Week Range

Low 50.75 High 91.87
63.79

BIOFIL CHEM & PHARMA LTD Share Price

4136

524396

BIOFILCHEM

img img img img
No Data Available

Open Price

64.55

Prev. Close

64.68

Volume (Shares)

27581.00

Total traded value

17.59

Upper Circuit

77.61

Lower Circuit

51.74

Note: The current prices & values are delayed, Login to your account for live updates.

BIOFIL CHEM & PHARMA LTD Fundamentals


(Standalone)

Market Cap (Cr) 103.80
PE Ratio (TTM) 196.03
Book Value / Share 11.30
Beta 1.21
ROE 1.42%
EPS (TTM) 0.33
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.02

BIOFIL CHEM & PHARMA LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 2.41
Operating Expense 2.40
Net Profit 0.02
Net Profit Margin (%) 0.82
Earnings Per Share (EPS) 0.01
EBITDA 0.14
Effective Tax Rate (%) 33.33
Particulars JUN 2024 (Values in Cr)
Revenue 8.44
Operating Expense 8.24
Net Profit 0.17
Net Profit Margin (%) 2.01
Earnings Per Share (EPS) 0.10
EBITDA 0.34
Effective Tax Rate (%) 26.08
Particulars MAR 2024 (Values in Cr)
Revenue 15.20
Operating Expense 15.33
Net Profit 0.25
Net Profit Margin (%) 1.64
Earnings Per Share (EPS) 0.15
EBITDA 0.37
Effective Tax Rate (%) 11.11
Particulars DEC 2023 (Values in Cr)
Revenue 5.03
Operating Expense 4.95
Net Profit 0.09
Net Profit Margin (%) 1.78
Earnings Per Share (EPS) 0.06
EBITDA 0.22
Effective Tax Rate (%) 18.18
Particulars SEP 2023 (Values in Cr)
Revenue 17.37
Operating Expense 17.25
Net Profit 0.12
Net Profit Margin (%) 0.69
Earnings Per Share (EPS) 0.08
EBITDA 0.27
Effective Tax Rate (%) 20.00
Particulars MAR 2024 (Values in Cr)
Revenue 40.04
Operating Expense 39.66
Net Profit 0.71
Net Profit Margin (%) 1.77
Earnings Per Share (EPS) 0.44
EBITDA 1.31
Effective Tax Rate (%) 18.39
Particulars MAR 2023 (Values in Cr)
Revenue 30.04
Operating Expense 29.34
Net Profit 0.56
Net Profit Margin (%) 1.86
Earnings Per Share (EPS) 0.29
EBITDA 1.26
Effective Tax Rate (%) 29.11
Particulars MAR 2022 (Values in Cr)
Revenue 22.38
Operating Expense 21.52
Net Profit 0.70
Net Profit Margin (%) 3.12
Earnings Per Share (EPS) 0.44
EBITDA 1.48
Effective Tax Rate (%) 31.68
Particulars MAR 2021 (Values in Cr)
Revenue 35.75
Operating Expense 34.63
Net Profit 1.24
Net Profit Margin (%) 3.46
Earnings Per Share (EPS) 0.76
EBITDA 2.40
Effective Tax Rate (%) 35.41
Particulars MAR 2020 (Values in Cr)
Revenue 29.69
Operating Expense 28.40
Net Profit 1.21
Net Profit Margin (%) 4.07
Earnings Per Share (EPS) 0.76
EBITDA 1.99
Effective Tax Rate (%) 17.80
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.19
ROE % 1.42
ROCE % 1.81
Total Debt to Total Equity 0.03
EBITDA Margin 3.25
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.63
ROE % 1.12
ROCE % 1.65
Total Debt to Total Equity 0.03
EBITDA Margin 4.19
Particulars MAR 2022 (Values in Cr)
Book Value / Share 10.35
ROE % 1.40
ROCE % 2.11
Total Debt to Total Equity 0.03
EBITDA Margin 6.61
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.91
ROE % 2.49
ROCE % 3.92
Total Debt to Total Equity 0.05
EBITDA Margin 6.71
Particulars MAR 2020 (Values in Cr)
Book Value / Share 9.15
ROE % 2.43
ROCE % 3.10
Total Debt to Total Equity 0.10
EBITDA Margin 6.70
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.28
Total Assets 47.08
Total Liabilities 47.08
Total Equity 18.20
Share Outstanding 16273800
Price to Book Ratio 5.39
Return on Assets (%) 1.50
Return on Capital (%) 3.8
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 31.40
Total Liabilities 31.40
Total Equity 17.30
Share Outstanding 16273800
Price to Book Ratio 3.90
Return on Assets (%) 1.78
Return on Capital (%) 3.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 18.73
Total Liabilities 18.73
Total Equity 16.83
Share Outstanding 16273800
Price to Book Ratio 5.58
Return on Assets (%) 3.72
Return on Capital (%) 4.04
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 33.23
Total Liabilities 33.23
Total Equity 16.12
Share Outstanding 16273800
Price to Book Ratio 6.62
Return on Assets (%) 3.73
Return on Capital (%) 7.5
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 42.36
Total Liabilities 42.36
Total Equity 14.88
Share Outstanding 16273800
Price to Book Ratio 0.81
Return on Assets (%) 2.84
Return on Capital (%) 7.51
Particulars MAR 2024 (Values in Cr)
Net Income 0.86
Cash from Operations 2.54
Cash from Investing -0.02
Cash from Financing -0.12
Net change in Cash 2.24
Free Cash Flow 2.57
Particulars MAR 2023 (Values in Cr)
Net Income 0.79
Cash from Operations 0.12
Cash from Investing -0.01
Cash from Financing 0.01
Net change in Cash -0.10
Free Cash Flow 0.13
Particulars MAR 2022 (Values in Cr)
Net Income 1.01
Cash from Operations 0.09
Cash from Investing -0.06
Cash from Financing 0.00
Net change in Cash -0.29
Free Cash Flow 0.16
Particulars MAR 2021 (Values in Cr)
Net Income 1.91
Cash from Operations 1.78
Cash from Investing -0.09
Cash from Financing -0.83
Net change in Cash 0.18
Free Cash Flow 2.35
Particulars MAR 2020 (Values in Cr)
Net Income 1.46
Cash from Operations 1.15
Cash from Investing -0.20
Cash from Financing -0.56
Net change in Cash 0.11
Free Cash Flow 1.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 37.45 3.55 499.34 37.54 / 77.70
BLISS GVS PHARMA LTD 151.80 19.00 1.58 1598.94 92.25 / 172.40
CIPLA LTD 1454.20 25.44 4.14 117443.01 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 410.00 142.36 4.15 1206.67 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2345.45 49.56 23.75 39733.34 1664.75 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.16 56.66 11.07 499.34 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.55 45.59 7.27 2167.00 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6595.05 128.08 24.26 16487.63 4050.15 / 8139.85
BLISS GVS PHARMA LTD 151.80 19.79 1.56 1598.94 92.25 / 172.40

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 64.90
  • 26 Days 64.70
  • 10 Days 64.50
  • 50 Days 67.50
  • 12 Days 64.10
  • 100 Days 66.90
  • 20 Days 63.90
  • 200 Days 72.70
64.92
PIVOT
First Resistance 65.74
Second Resistance 66.79
Third Resistance 67.61
First Support 63.87
Second Support 63.05
Third Support 62.00
RSI 49.45
MACD -0.62
Commodity Channel Index (CCI) 62.21
ADX 21.59
Williams % R -38.04

Over 1 Month

down

0.27

Over 3 Months

down

-0.85

Over 6 Months

down

1.57

Over 1 Year

down

24.98

Over 3 Years

down

2.33

Over 5 Years

down

39.37

BIOFIL CHEM & PHARMA LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

BIOFIL CHEM & PHARMA LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
0.0
Promoter Holdings
0.0
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%

BIOFIL CHEM & PHARMA LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About BIOFIL CHEM & PHARMA LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by BIOFIL CHEM & PHARMA LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

The share price of Biofil Chemicals & Pharmaceuticals Ltd for NSE is ₹ 63.33 and for BSE is ₹ 63.53.

What is the Market Cap of Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

The market cap of Biofil Chemicals & Pharmaceuticals Ltd for NSE is ₹ 1,03.80 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Biofil Chemicals & Pharmaceuticals Ltd for NSE is ₹ 91.87 and ₹ 50.75 and for BSE is ₹ 92.00 and ₹ 51.00.

How to Buy Biofil Chemicals & Pharmaceuticals Ltd share?

Answer Field

You can trade in Biofil Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 24.98%.

What is the Current Share Price of Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

Biofil Chemicals & Pharmaceuticals Ltd share price is for NSE ₹ 63.33 & for BSE ₹ 63.53 as on Dec 12 2024 03:30 PM.

What is the Market Cap of Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

The market cap of Biofil Chemicals & Pharmaceuticals Ltd for NSE ₹ 1,03.80 & for BSE ₹ 0.0 as on Dec 12 2024 03:30 PM.

What is the P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM the price-to-earnings (PE) ratio for Biofil Chemicals & Pharmaceuticals Ltd share is 196.03.

What is the PB ratio of Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Dec 12 2024 03:30 PM, the price-to-book (PB) ratio for Biofil Chemicals & Pharmaceuticals Ltd share is 11.30.

How to Buy Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

You can trade in Biofil Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Biofil Chemicals & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Biofil Chemicals & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Biofil Chemicals & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader